Clinical Research
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
474
NCT04380519
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)
Phase: Phase 2/3
Role: Collaborator
Start: Apr 23, 2020
Completion: Jul 24, 2020
NCT04463251
Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction
Phase: Phase 2
Start: Dec 7, 2020
Completion: Oct 10, 2022
Loading map...